Merck and Endocyte announce acceptance for review of European Marketing Authorization applications for vintafolide and companion Diagnostic etarfolatide for folate-receptor positive platinum-resistant ovarian cancer
Novel personalized treatment approach targets folate receptors on cancer cells...
27 November 2012 | By Merck
Novel personalized treatment approach targets folate receptors on cancer cells...